FI57405C - Foerfarande foer framstaellning av nya kolesterol- och fetthalt saenkande 2-(substituerad isopropyl)- 2-oxazolinderivat - Google Patents

Foerfarande foer framstaellning av nya kolesterol- och fetthalt saenkande 2-(substituerad isopropyl)- 2-oxazolinderivat Download PDF

Info

Publication number
FI57405C
FI57405C FI3243/73A FI324373A FI57405C FI 57405 C FI57405 C FI 57405C FI 3243/73 A FI3243/73 A FI 3243/73A FI 324373 A FI324373 A FI 324373A FI 57405 C FI57405 C FI 57405C
Authority
FI
Finland
Prior art keywords
isopropyl
hydroxymethyl
oxazoline
mol
yield
Prior art date
Application number
FI3243/73A
Other languages
English (en)
Finnish (fi)
Other versions
FI57405B (fi
Inventor
Istvan Tibor Toth
Pal Bite
Gyoergy Magyar
Esztor Diszler
Jozsef Borsi
Andrea Maderspach
Istvan Polgari
Sandor Elek
Istvan Elekes
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of FI57405B publication Critical patent/FI57405B/fi
Application granted granted Critical
Publication of FI57405C publication Critical patent/FI57405C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI3243/73A 1972-10-20 1973-10-18 Foerfarande foer framstaellning av nya kolesterol- och fetthalt saenkande 2-(substituerad isopropyl)- 2-oxazolinderivat FI57405C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUGO1222A HU167760B (pl) 1972-10-20 1972-10-20
HUGO001222 1972-10-20

Publications (2)

Publication Number Publication Date
FI57405B FI57405B (fi) 1980-04-30
FI57405C true FI57405C (fi) 1980-08-11

Family

ID=10996737

Family Applications (1)

Application Number Title Priority Date Filing Date
FI3243/73A FI57405C (fi) 1972-10-20 1973-10-18 Foerfarande foer framstaellning av nya kolesterol- och fetthalt saenkande 2-(substituerad isopropyl)- 2-oxazolinderivat

Country Status (21)

Country Link
US (1) US3979405A (pl)
JP (1) JPS4972250A (pl)
AT (1) AT331791B (pl)
BE (1) BE806342A (pl)
CA (1) CA1021343A (pl)
CH (1) CH602677A5 (pl)
CS (1) CS181838B1 (pl)
DD (1) DD108753A1 (pl)
DE (1) DE2352055A1 (pl)
DK (1) DK135991B (pl)
ES (1) ES419969A1 (pl)
FI (1) FI57405C (pl)
FR (1) FR2203633B1 (pl)
GB (1) GB1426028A (pl)
HU (1) HU167760B (pl)
NL (1) NL7314414A (pl)
NO (1) NO141648C (pl)
PL (1) PL89478B1 (pl)
SE (1) SE386173B (pl)
SU (1) SU539528A3 (pl)
YU (1) YU273973A (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4119633A (en) * 1972-10-20 1978-10-10 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. 2-Phenoxy and 2-phenylthio and 2-phenylamino-alkyl-2-oxazolines
CA1056842A (en) * 1975-06-12 1979-06-19 Masayuki Narisada Dihydroethanoanthracene derivatives
GB1518280A (en) * 1976-09-15 1978-07-19 Texaco Development Corp Method of preparing alpha-vinyloxazolines
US4294966A (en) * 1978-07-28 1981-10-13 Ciba-Geigy Corporation Process for inverting the configuration in optically active compounds
US4205176A (en) * 1978-10-18 1980-05-27 Cincinnati Milacron Chemicals Inc. Ester substituted oxazolines
US5227494A (en) * 1988-09-14 1993-07-13 Schering Corporation Process for preparing oxazoline compounds
EP0434731A1 (en) * 1988-09-14 1991-07-03 Schering Corporation Process for preparing oxazoline compounds
PL166385B1 (en) * 1990-10-25 1995-05-31 Schering Corp Method of obtaining oxazoline compound
CA2308415A1 (en) 1997-11-12 1999-05-20 The Penn State Research Foundation Transition metal-catalyzed reactions based on chiral amine oxazolinyl ligands
US6476233B1 (en) 1998-11-12 2002-11-05 The Penn State Research Foundation Transition metal-catalyzed reactions based on chiral amine oxazolinyl ligands and related compounds
US8354441B2 (en) * 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US8673950B2 (en) * 2010-11-02 2014-03-18 Hoffmann-Laroche Inc. Dihydrooxazol-2-amine derivatives
US9550955B2 (en) 2012-12-21 2017-01-24 Afton Chemical Corporation Friction modifiers for lubricating oils

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2579478A (en) * 1951-12-25 Heterocyclic compounds
NL124622C (pl) * 1963-05-02
US3637726A (en) * 1970-04-09 1972-01-25 Dow Chemical Co Substituted-5-((3 4-dihalophenoxy)methyl)-2-oxazoline compounds
US3778445A (en) * 1971-06-28 1973-12-11 Scott & Sons Co O M Phenoxyalkyloxazolines

Also Published As

Publication number Publication date
CS181838B1 (en) 1978-03-31
FI57405B (fi) 1980-04-30
YU273973A (en) 1980-10-31
CH602677A5 (pl) 1978-07-31
CA1021343A (en) 1977-11-22
GB1426028A (en) 1976-02-25
NO141648B (no) 1980-01-07
PL89478B1 (en) 1976-06-30
SE386173B (sv) 1976-08-02
FR2203633A1 (pl) 1974-05-17
NO141648C (no) 1980-04-16
BE806342A (fr) 1974-02-15
HU167760B (pl) 1975-12-25
SU539528A3 (ru) 1976-12-15
DD108753A1 (pl) 1974-10-05
US3979405A (en) 1976-09-07
JPS4972250A (pl) 1974-07-12
AT331791B (de) 1976-08-25
NL7314414A (pl) 1974-04-23
ATA883573A (de) 1975-12-15
FR2203633B1 (pl) 1976-07-02
DK135991C (pl) 1977-12-27
ES419969A1 (es) 1976-08-01
DK135991B (da) 1977-07-25
DE2352055A1 (de) 1974-05-09

Similar Documents

Publication Publication Date Title
FI57405B (fi) Foerfarande foer framstaellning av nya kolesterol- och fetthalt saenkande 2-(substituerad isopropyl)- 2-oxazolinderivat
SU1333240A3 (ru) Способ получени производных метилендифосфоновой кислоты
EP0283742B1 (en) Fatty acid amides as inhibitors of acyl-coa: cholesterol acyltransferase
CA1300619C (en) 1-(4-hydroxy-3,5-di-tert.-butylbenzoyl)homopiperazine, various derivatives thereof, processes for the preparation of these compounds, medicaments containing them, and their use
DE3239157A1 (de) Derivate der 3-amino-2-azetidinon-1-sulfonsaeure, ihre herstellung, zwischenprodukte und pharmazeutische zusammensetzungen
FR2573075A1 (fr) Nouvelles (pyridyl-2)-1 piperazines, leur procede de preparation et leur application en therapeutique
SU1419520A3 (ru) Способ получени производных метилендифосфоновой кислоты и ее щелочных солей
DE1770595C3 (de) 2-(N-lsopropylaminomethyl)-7-nitro-1,2,3,4-tetrahydrochinolinderivate und deren pharmazeutisch verträgliche Säureadditionssalze
US3839347A (en) 1-aminobenzimidazoles
US4153728A (en) Phenoxyalkylcarboxylic acid compounds and therapeutic compositions
DE3049405A1 (de) Neue derivate von antiphlogistisch wirksamen carbonsaeuren, ihre herstellung und medizinische anwendung
EP0096870B1 (en) Ester of metronidazole with n,n-dimethylglycine and acid addition salt thereof
DE69103968T2 (de) 2-(Aminoalkyl)-5-(arylalkyl)1,3-dioxanderivate, ihre Herstellung und ihre Anwendung in der Therapeutik.
US3686110A (en) 1-oxybenzimidazoles
US4034102A (en) 4-Substituted-1,3-dithiolan-2-ylidene malonates and pharmaceutical compositions containing the same
JP4384495B2 (ja) 固体のベンズアゼピン化合物の塩および医薬化合物の調製におけるそれらの使用
EP0445073A1 (de) Benzofurane
EP0144845B1 (en) Indolylacetic acid derivatives and preparations containing same for medical treatments
US4521417A (en) Geranylgeranylacetamide compounds having a piperazine ring, salts thereof, pharmaceutical compositions containing said compounds, and method of treating ulcers in mammals
EP0057572B1 (en) Alkanolamine derivatives
US4521619A (en) Therapeutically useful sulphur-containing benzylidene derivatives
HU182705B (en) Process for producing substituted triaryl-tiazole-derivatives
SU1165231A3 (ru) Способ получени @ -замещенных 3-циклоалкилсульфонилпирролидиндиона-2,5
SU927109A3 (ru) Способ получени замещенных фенилалканкарбоновых кислот
US4221739A (en) Amino-substituted nitrobenzophenone derivatives with alkyl, phenyl, phenyl alkyl or cycloalkyl amino-substituting groups